Boswood to head Thomson Healthcare

Share this article:

Thomson Healthcare has named Mike Boswood president and CEO, replacing Bob Cullen, who is retiring after 23 years at the company.

Boswood, who is based in London but will move to Ann Arbor, MI, in his new role, was previously president and CEO of Thomson International Legal and Regulatory, where he is credited with delivering solid operating performance, championing numerous growth initiatives and building a strong management team. He also serves as president of the Publisher's Association in the UK. Before joining Thomson in 1997, he served in a number of senior roles at Reed Elsevier, including president, Elsevier Science Inc. in the US, and as managing director of Elsevier Science in the UK. 

Cullen, then president and CEO of Thomson Scientific and Healthcare, took over as the

operational head of the company's healthcare division in 2006, following the resignation of Kevin King.

The company has retooled its healthcare offering in recent years, divesting its journals and med ed business to focus on data and analytics. Thomson sold off its medical publishing business, including the Medical Economics franchise, to Advanstar in 2003, and sold Thomson Medical Education (since rebranded to KnowledgePoint360) to a private equity firm in 2006 while acquiring Solucient. 

Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Journal Ad Review: Reality Bites

Journal Ad Review: Reality Bites

Print's numbers may be taking some small steps in the right direction, but data is what the industry really wants to sink its teeth into. Larry Dobrow reports on what ...

Headliner: Proteus CEO takes an original path

Headliner: Proteus CEO takes an original path

Andrew Thompson, CEO, Proteus Digital Health

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...